Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Failure of Cyclophosphamide Therapy in Lupus Nephritis Patients: the Role of Bioactivation Phenotype and Genotype

NCT00441220 is registered in ClinicalTrials.gov with University of Auckland, New Zealand as lead sponsor.

NCT NCT00441220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00441220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Failure of Cyclophosphamide Therapy in Lupus Nephritis Patients: the Role of Bioactivation Phenotype and Genotype
Lead sponsor
University of Auckland, New Zealand
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2006
Completion date
October 31, 2010
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus